SFC

Sommaire


CARDIOLOGIE PÉDIATRIQUE

  • 📌 À LA UNE : Impact of Fontan fenestration on adverse cardiovascular outcomes: a multicenter study | Lire l'article CJC
  • Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023 | Lire l'article The American Journal of Cardiology
  • Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in Children | Lire l'article JACC
  • Contemporary Care and Outcomes of Critically-ill Children With Clinically Diagnosed Myocarditis | Lire l'article JCF
  • Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease | Lire l'article JAHA
  • Diagnostic approach to the Pediatric Brugada Syndrome: A survey of international common practice | Lire l'article Heart Rhythm Journal
  • Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association | Lire l'article Circulation
  • Post-ligation cardiac syndrome after surgical versus transcatheter closure of patent ductus arteriosus in low body weight premature infants: a multicenter retrospective cohort study | Lire l'article European Journal of Pediatrics
  • The c.1617del variant of TMEM260 is identified as the most frequent single gene determinant for Japanese patients with a specific type of congenital heart disease | Lire l'article Journal of Human Genetics

CARDIO-ONCOLOGIE

  • 📌 À LA UNE : Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration | Lire l'article JAMA Network

CORONAIRES ET INTERVENTIONNEL

  • 📌 À LA UNE : Prognostic Implications of Quantitative Flow Ratio and Plaque Characteristics in Intravascular Ultrasound–Guided Treatment Strategy | Lire l'article JACC
  • A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study | Lire l'article JACC
  • Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease | Lire l'article JACC
  • Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000 | Lire l'article JACC
  • Percutaneous Left Ventricular Unloading During High-Risk Coronary Intervention: Rationale and Design of the CHIP-BCIS3 Randomized Controlled Trial | Lire l'article Circulation
  • Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial | Lire l'article Circulation
  • Presence and Relevance of Myocardial Bridge in LAD-PCI of CTO and Non-CTO Lesions | Lire l'article JACC
  • Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease | Lire l'article JACC

HTA

IMAGERIE CARDIOVASCULAIRE

INSUFFISANCE CARDIAQUE ET CARDIOMYOPATHIES

RISQUE CARDIOVASCULAIRE

RYTHMOLOGIE

  • 📌 À LA UNE : Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review | Lire l'article JACC
  • Conduction System Pacing versus Biventricular Pacing in Heart Failure with Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled | Lire l'article Heart Rhythm Journal
  • Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography | Lire l'article JACC 
  • Nitroglycerin to Ameliorate Coronary Artery Spasm During Focal Pulsed-Field Ablation for Atrial Fibrillation | Lire l'article JACC
  • Predicting Major Adverse Events in Patients Undergoing Transcatheter Left Atrial Appendage Occlusion | Lire l'article Circulation
  • Ventricular Tachycardia Ablation Endpoints: Moving Beyond Noninducibility | Lire l'article JACC

USIC

VALVULOPATHIES

  • 📌 À LA UNE : Association Between Clinical Trial Participation Status and Outcomes With Mitral Transcatheter Edge-to-Edge Repair | Lire l'article JACC
  • Applying the TRILUMINATE Eligibility Criteria to Real-World Patients Receiving Tricuspid Valve Transcatheter Edge-to-Edge Repair | Lire l'article JACC
  • Assessment of Suitability for Percutaneous Mitral Commissurotomy: A Contemporary Review of Key Anatomical Criteria and Predictive Models | Lire l'article European Heart Journal
  • EACVI survey on the evaluation of mitral regurgitation | Lire l'article European Heart Journal
  • Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation | Lire l'article Circulation
  • Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry | Lire l'article JACC
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial | Lire l'article Circulation

DEEP LEARNING ET INTELLIGENCE ARTIFICIELLE

  • 📌 À LA UNE : Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association | Lire l'article Circulation
  • Automatic measurements of left ventricular volumes and ejection fraction by artificial intelligence: clinical validation in real time and large databases | Lire l'article European Heart Journal
  • Machine Learning-Based Discrimination of Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy | Lire l'article JACC

COVID

  • 📌 À LA UNE : Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction | Lire l'article JAMA

LA FRANCE À L’HONNEUR

Nos suggestions d’actualités

Les actualités Cardio Online

Muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

21/11/2024
Actualités Communautés
Newsletter

Newsletter de la SFHTA - Novembre 2024

21/11/2024
Actualités Congrès
Congrès

Impact environnemental de la cardiologie : Participez à notre enquête nationale !

20/11/2024
Actualités Communautés
Communautés

Congrès FCPC 2027 et 2028 : Appel à candidatures